Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Germaine™ Laboratories DOA Positive Control

Germaine™ Laboratories AimScreen™ DOA Controls monitor and validate performance of DOA detection methods at levels established by SAMHSA, CAP/AACC and many state programs

Supplier:  Germaine™ Laboratories 40002

Catalog No. 23-111-316


Add to Cart
This item is not returnable. View return policy

Description

Description

  • Compatible with all quantitative and qualitative drug detection procedures which are sufficiently sensitive to detect the control constituents
  • Positive control urines have been spiked with authentic reference drug standards and/or appropriate metabolites
  • Should be treated as any unknown specimen while following the specific protocol of the assay being used
  • Controls prepared from human based urine available as a negative
  • Cutoff is +3x to monitor the performance of drugs of abuse test devices
  • Each bottle contains stabilized human based urine
  • Human urine based matrix
Specifications

Specifications

2°C to 8°C
AMP, BAR, Buprenorphine, BZO, COC, MDMA, mAMP, MOP, MTD, OPI, Oxycodone, PCP, PPx, TCA, THC
All quantitative and qualitative drug detection procedures which are sufficiently sensitive to detect the control constituents.
1 x 5 mL
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit